Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The acellular pertussis vaccine trials: an interpretation.

× No keyword cloud information.

15 in total

1. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors: C L Weingart; A A Weiss
Journal: Infect Immun Date: 2000-03 Impact factor: 3.441

2. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors: C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal: Infect Immun Date: 2000-12 Impact factor: 3.441

3. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors: C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal: Infect Immun Date: 2000-12 Impact factor: 3.441

4. Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.

Authors: G Tormans; E Van Doorslaer; P van Damme; R Clara; H J Schmitt
Journal: Eur J Pediatr Date: 1998-05 Impact factor: 3.183

5. Composition of pertussis vaccine given to infants determines long-term T cell polarization.

Authors: Stanley A Plotkin
Journal: J Clin Invest Date: 2018-08-06 Impact factor: 14.808

Review 6. What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors: Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal: Cold Spring Harb Perspect Biol Date: 2017-12-01 Impact factor: 10.005

Review 7. Which strategy for pertussis vaccination today?

Authors: Dorota Z Girard
Journal: Paediatr Drugs Date: 2002 Impact factor: 3.022

Review 8. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors: Janet R Casey; Michael E Pichichero
Journal: Drugs Date: 2005 Impact factor: 9.546

9. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.

Authors: Sylvie Alonso; Nathalie Reveneau; Kévin Pethe; Camille Locht
Journal: Infect Immun Date: 2002-08 Impact factor: 3.441

10. Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.

Authors: Rachel M Stenger; Martien C M Poelen; Ed E Moret; Betsy Kuipers; Sven C M Bruijns; Peter Hoogerhout; Marcel Hijnen; Audrey J King; Frits R Mooi; Claire J P Boog; Cécile A C M van Els
Journal: Infect Immun Date: 2008-11-17 Impact factor: 3.441